article thumbnail

New Insulin Price Cap Could End Up Saving Payers Money in the Long Run

HR Digest

Reducing out-of-pocket cost-sharing for insulin does mean payers and insurers may be covering a greater share of the costs. However, some of those costs may be offset by increased medication adherence and reduced hospitalization rates, which would end up saving payers money in the long run.